Cargando…
Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice
BACKGROUND: Asthma leads to structural changes in the airways, including the modification of extracellular matrix proteins such as tenascin-C. The role of tenascin-C is unclear, but it might act as an early initiator of airway wall remodelling, as its expression is increased in the mouse and human a...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024219/ https://www.ncbi.nlm.nih.gov/pubmed/21205293 http://dx.doi.org/10.1186/1465-9921-12-2 |
_version_ | 1782196736560726016 |
---|---|
author | Meuronen, Anna Karisola, Piia Leino, Marina Savinko, Terhi Sirola, Kristiina Majuri, Marja-Leena Piirilä, Päivi Virtanen, Ismo Mäkelä, Mika Laitinen, Annika Laitinen, Lauri A Alenius, Harri |
author_facet | Meuronen, Anna Karisola, Piia Leino, Marina Savinko, Terhi Sirola, Kristiina Majuri, Marja-Leena Piirilä, Päivi Virtanen, Ismo Mäkelä, Mika Laitinen, Annika Laitinen, Lauri A Alenius, Harri |
author_sort | Meuronen, Anna |
collection | PubMed |
description | BACKGROUND: Asthma leads to structural changes in the airways, including the modification of extracellular matrix proteins such as tenascin-C. The role of tenascin-C is unclear, but it might act as an early initiator of airway wall remodelling, as its expression is increased in the mouse and human airways during allergic inflammation. In this study, we examined whether Th1 or Th2 cells are important regulators of tenascin-C in experimental allergic asthma utilizing mice with impaired Th1 (STAT4-/-) or Th2 (STAT6-/-) immunity. METHODS: Balb/c wildtype (WT), STAT4-/- and STAT6-/- mice were sensitized with intraperitoneally injected ovalbumin (OVA) followed by OVA or PBS airway challenge. Airway hyperreactivity (AHR) was measured and samples were collected. Real time PCR and immunohistochemistry were used to study cytokines and differences in the expression of tenascin-C. Tenascin-C expression was measured in human fibroblasts after treatment with TNF-α and IFN-γ in vitro. RESULTS: OVA-challenged WT mice showed allergic inflammation and AHR in the airways along with increased expression of TNF-α, IFN-γ, IL-4 and tenascin-C in the lungs. OVA-challenged STAT4-/- mice exhibited elevated AHR and pulmonary eosinophilia. The mRNA expression of TNF-α and IFN-γ was low, but the expression of IL-4 was significantly elevated in these mice. OVA-challenged STAT6-/- mice had neither AHR nor pulmonary eosinophilia, but had increased expression of mRNA for TNF-α, IFN-γ and IL-4. The expression of tenascin-C in the lungs of OVA-challenged STAT4-/- mice was weaker than in those of OVA-challenged WT and STAT6-/- mice suggesting that TNF-α and IFN-γ may regulate tenascin-C expression in vivo. The stimulation of human fibroblasts with TNF-α and IFN-γ induced the expression of tenascin-C confirming our in vivo findings. CONCLUSIONS: Expression of tenascin-C is significantly attenuated in the airways of STAT4-/- mice, which may be due to the impaired secretion of TNF-α and IFN-γ in these mice. |
format | Text |
id | pubmed-3024219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30242192011-01-21 Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice Meuronen, Anna Karisola, Piia Leino, Marina Savinko, Terhi Sirola, Kristiina Majuri, Marja-Leena Piirilä, Päivi Virtanen, Ismo Mäkelä, Mika Laitinen, Annika Laitinen, Lauri A Alenius, Harri Respir Res Research BACKGROUND: Asthma leads to structural changes in the airways, including the modification of extracellular matrix proteins such as tenascin-C. The role of tenascin-C is unclear, but it might act as an early initiator of airway wall remodelling, as its expression is increased in the mouse and human airways during allergic inflammation. In this study, we examined whether Th1 or Th2 cells are important regulators of tenascin-C in experimental allergic asthma utilizing mice with impaired Th1 (STAT4-/-) or Th2 (STAT6-/-) immunity. METHODS: Balb/c wildtype (WT), STAT4-/- and STAT6-/- mice were sensitized with intraperitoneally injected ovalbumin (OVA) followed by OVA or PBS airway challenge. Airway hyperreactivity (AHR) was measured and samples were collected. Real time PCR and immunohistochemistry were used to study cytokines and differences in the expression of tenascin-C. Tenascin-C expression was measured in human fibroblasts after treatment with TNF-α and IFN-γ in vitro. RESULTS: OVA-challenged WT mice showed allergic inflammation and AHR in the airways along with increased expression of TNF-α, IFN-γ, IL-4 and tenascin-C in the lungs. OVA-challenged STAT4-/- mice exhibited elevated AHR and pulmonary eosinophilia. The mRNA expression of TNF-α and IFN-γ was low, but the expression of IL-4 was significantly elevated in these mice. OVA-challenged STAT6-/- mice had neither AHR nor pulmonary eosinophilia, but had increased expression of mRNA for TNF-α, IFN-γ and IL-4. The expression of tenascin-C in the lungs of OVA-challenged STAT4-/- mice was weaker than in those of OVA-challenged WT and STAT6-/- mice suggesting that TNF-α and IFN-γ may regulate tenascin-C expression in vivo. The stimulation of human fibroblasts with TNF-α and IFN-γ induced the expression of tenascin-C confirming our in vivo findings. CONCLUSIONS: Expression of tenascin-C is significantly attenuated in the airways of STAT4-/- mice, which may be due to the impaired secretion of TNF-α and IFN-γ in these mice. BioMed Central 2011 2011-01-04 /pmc/articles/PMC3024219/ /pubmed/21205293 http://dx.doi.org/10.1186/1465-9921-12-2 Text en Copyright ©2011 Meuronen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Meuronen, Anna Karisola, Piia Leino, Marina Savinko, Terhi Sirola, Kristiina Majuri, Marja-Leena Piirilä, Päivi Virtanen, Ismo Mäkelä, Mika Laitinen, Annika Laitinen, Lauri A Alenius, Harri Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title | Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title_full | Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title_fullStr | Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title_full_unstemmed | Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title_short | Attenuated expression of tenascin-c in ovalbumin-challenged STAT4-/- mice |
title_sort | attenuated expression of tenascin-c in ovalbumin-challenged stat4-/- mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024219/ https://www.ncbi.nlm.nih.gov/pubmed/21205293 http://dx.doi.org/10.1186/1465-9921-12-2 |
work_keys_str_mv | AT meuronenanna attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT karisolapiia attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT leinomarina attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT savinkoterhi attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT sirolakristiina attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT majurimarjaleena attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT piirilapaivi attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT virtanenismo attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT makelamika attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT laitinenannika attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT laitinenlauria attenuatedexpressionoftenascincinovalbuminchallengedstat4mice AT aleniusharri attenuatedexpressionoftenascincinovalbuminchallengedstat4mice |